Kimura H, Konishi K, Maeda K, Yabushita K, Tsuji M, Miwa A
Department of Surgery, Toyama Prefectural Central Hospital, Toyama, Japan.
Dig Surg. 1999;16(2):152-7. doi: 10.1159/000018709.
The purpose of this study was to determine the clinical course, and effects of the histopathologic characteristics of specific tumors, including DNA contents and immunohistochemical aspects, in patients with small-cell carcinoma of the alimentary tract. Medical records of 14 patients who presented with small-cell carcinoma of the alimentary tract were retrospectively reviewed. Primary tumors were studied by immunohistochemical and flow cytometric analyses. Of these 14 small-cell carcinomas, 4 were esophageal, 8 gastric, and 2 colonic tumors. DNA aneuploidy was observed in 8 tumors. Staining for the p53 product was positive in 57.1% of all the tumors. The average proliferating cell nuclear antigen (PCNA) labeling rate (LR) was 72.4 +/- 11.6%. The average PCNA LR was significantly higher for the p53-positive group (p < 0.05). The estimated median survival was 253 days for all patients. Noncurative resection was associated with a significantly less favorable prognosis (p < 0.01). Distant metastases were observed in 13 of 14 patients. A higher PCNA LR of small-cell carcinoma may be an unfavorable characteristic of biological behavior. The patients with disseminated disease should undergo a symptomatically palliative operation combined with chemotherapy.
本研究的目的是确定消化道小细胞癌患者的临床病程,以及特定肿瘤的组织病理学特征(包括DNA含量和免疫组化方面)的影响。对14例消化道小细胞癌患者的病历进行了回顾性分析。对原发性肿瘤进行了免疫组化和流式细胞术分析。在这14例小细胞癌中,4例为食管癌,8例为胃癌,2例为结肠癌。8例肿瘤观察到DNA非整倍体。所有肿瘤中57.1%的p53产物染色呈阳性。增殖细胞核抗原(PCNA)标记率(LR)平均为72.4±11.6%。p53阳性组的平均PCNA LR显著更高(p<0.05)。所有患者的估计中位生存期为253天。非根治性切除与预后明显较差相关(p<0.01)。14例患者中有13例出现远处转移。小细胞癌较高的PCNA LR可能是生物学行为的不良特征。播散性疾病患者应接受对症姑息手术联合化疗。